Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Listening to Bluetooth Beacons for Epidemic Risk Mitigation

Gilles Barthe, Roberta De Viti, Peter Druschel, Deepak Garg, Manuel Gomez-Rodriguez, Pierfrancesco Ingo, Heiner Kremer, Matthew Lentz, Lars Lorch, Aastha Mehta, Bernhard Schölkopf
doi: https://doi.org/10.1101/2021.01.21.21250209
Gilles Barthe
1Max Planck Institute for Security and Privacy, Bochum, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberta De Viti
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Druschel
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepak Garg
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Gomez-Rodriguez
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bs@tuebingen.mpg.de
Pierfrancesco Ingo
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heiner Kremer
3Max Planck Institute for Intelligent Systems, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Lentz
4VMware Research, Palo Alto, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Lorch
5ETH Zürich, Zürich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aastha Mehta
2Max Planck Institute for Software Systems, Saarbrücken and Kaiserslautern, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Schölkopf
3Max Planck Institute for Intelligent Systems, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bs@tuebingen.mpg.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

During the ongoing COVID-19 pandemic, there have been burgeoning efforts to develop and deploy smartphone apps to expedite contact tracing and risk notification. Unfortunately, the success of these apps has been limited, partly owing to poor interoperability with manual contact tracing, low adoption rates, and a societally sensitive trade-off between utility and privacy. In this work, we introduce a new privacy-preserving and inclusive system for epidemic risk assessment and notification that aims to address the above limitations. Rather than capturing pairwise encounters between smartphones as done by existing apps, our system captures encounters between inexpensive, zero-maintenance, small devices carried by users, and beacons placed in strategic locations where infection clusters are most likely to originate. Epidemiological simulations using an agent-based model demonstrate several beneficial properties of our system. By achieving bidirectional interoperability with manual contact tracing, our system can help control disease spread already at low adoption. By utilizing the location and environmental information provided by the beacons, our system can provide significantly higher sensitivity and specificity than existing app-based systems. In addition, our simulations also suggest that it is sufficient to deploy beacons in a small fraction of strategic locations for our system to achieve high utility.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the data used in the study is publicly available and is anonymized.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Code and data to reproduce our epidemiological simulations are available at https://github.com/covid19-model/simulator/tree/beacon.

https://github.com/covid19-model/simulator/tree/beacon

http://pancast.mpi-sws.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 26, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Listening to Bluetooth Beacons for Epidemic Risk Mitigation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Listening to Bluetooth Beacons for Epidemic Risk Mitigation
Gilles Barthe, Roberta De Viti, Peter Druschel, Deepak Garg, Manuel Gomez-Rodriguez, Pierfrancesco Ingo, Heiner Kremer, Matthew Lentz, Lars Lorch, Aastha Mehta, Bernhard Schölkopf
medRxiv 2021.01.21.21250209; doi: https://doi.org/10.1101/2021.01.21.21250209
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Listening to Bluetooth Beacons for Epidemic Risk Mitigation
Gilles Barthe, Roberta De Viti, Peter Druschel, Deepak Garg, Manuel Gomez-Rodriguez, Pierfrancesco Ingo, Heiner Kremer, Matthew Lentz, Lars Lorch, Aastha Mehta, Bernhard Schölkopf
medRxiv 2021.01.21.21250209; doi: https://doi.org/10.1101/2021.01.21.21250209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8542)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1741)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1235)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (371)
  • Infectious Diseases (except HIV/AIDS) (10274)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1668)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (111)
  • Palliative Medicine (40)
  • Pathology (251)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1760)
  • Public and Global Health (3829)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (318)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)